ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 113 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $8,000 | -11.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $9,000 | -25.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $12,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $12,000 | +9.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $11,000 | -31.2% | 1,500 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $16,000 | -30.4% | 1,500 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $23,000 | +91.7% | 1,500 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $12,000 | -52.0% | 1,500 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $25,000 | -10.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $28,000 | -17.6% | 1,500 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $34,000 | +6.2% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $32,000 | -5.9% | 1,500 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $34,000 | +54.5% | 1,500 | +50.0% | 0.01% | +66.7% |
Q2 2018 | $22,000 | -4.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $23,000 | -11.5% | 1,000 | 0.0% | 0.00% | -25.0% |
Q4 2017 | $26,000 | +18.2% | 1,000 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $22,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
Miura Global Management | 600,000 | $15,486,000 | 0.94% |
DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |